The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis
Wei-kang Xing,1 Chuan Shao,2 Zhen-yu Qi,1 Chao Yang,1 Zhong Wang1 1Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 2Department of Neurosurgery, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, Sichuan, People&rsquo...
Main Authors: | Xing WK, Shao C, Qi ZY, Yang C, Wang Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-06-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/the-role-of-gliadel-wafers-in-the-treatment-ofnbspnewly-diagnosed-gbm--peer-reviewed-article-DDDT |
Similar Items
-
Efficacy and Toxicity Profile of Carfilzomib-Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review
by: Imtiaz H, et al.
Published: (2021-10-01) -
Phase 2 clinical trial of VAL-083 as first-line treatment in newly-diagnosed MGMT-unmethylated glioblastoma multiforme (GBM): Halfway report
by: Chengcheng Guo, et al.
Published: (2019-01-01) -
Consolidation therapy of arsenic trioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed acute promyelocytic leukemia
by: Liu CC, et al.
Published: (2015-11-01) -
Adjuvant Treatment of Newly Diagnosed Breast Cancer
by: Bossaer, John B., et al.
Published: (2011) -
Biomarkers for treatment outcome in newly diagnosed epilepsy
by: Auce, P.
Published: (2017)